CAB LA + RPV LA, Oral ART — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-19 in 2mo
ESTIMATED |
READOUT
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + R
Phase 3 · HIV Infections |
ViiV Healthcare | CAB LA + RPV LA, Oral ART |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|